Search results
Results from the WOW.Com Content Network
Octodrine, also known as dimethylhexylamine (DMHA) and sold under the brand name Vaporpac among others, is a sympathomimetic and stimulant medication that was formerly used in the treatment of hypotension (low blood pressure).
(C 6 H 5) 3 CCl + 2 Na → (C 6 H 5) 3 CNa + NaCl. The use of tritylsodium as a strong, non-nucleophilic base has been eclipsed by the popularization of butyllithium and related strong bases. The unmodified anion is red, and can be used as an indicator in acid–base titrations. Derived substances have proven useful as chemical dyes.
Gabapentin is also associated with other intimate side effects, like difficulty reaching orgasm, although the science on this link isn’t totally clear. ED from gabapentin isn’t permanent.
Etizolam powder. Pictured is roughly 150 mg; a standard dose is around 1 mg Etizex brand etizolam tablets. Etizolam (marketed under numerous brand names) is a thienodiazepine derivative [5] which is a benzodiazepine analog. [6]
PRL-8-53 is relatively non-toxic, with an oral LD 50 in mice of 860 mg/kg, giving the drug a high therapeutic index. Doses above 8 mg/kg have brief hypotensive effects in canines. High doses depress motor activity in the rat and mouse, with the ED 50 for a 50% reduction in motor activity of mice at 160 mg/kg. PRL-8-53 displays spasmolytic ...
AG is used for adrenal steroidogenesis inhibition by mouth at a dosage of 250 mg three times per day (750 mg/day total) for the first 3 weeks of therapy and then increased to 250 mg four times per day (1,000 mg/day total) thereafter. [4] It can be used at a dosage of up to 500 mg four times per day (2,000 mg/day). [1] [8] It is used as an ...
The trials enrolled children and adults with LC-FAOD. [4] Trials 1 and 2 were conducted at 11 sites in the United States and the United Kingdom, and Trial 3 was conducted at two sites in the United States. [4] Trial 1 and Trial 2 were used to evaluate the side effects of triheptanoin. [4]
Betahistine was once believed to have some positive effects in the treatment of Ménière's disease and vertigo, [3] but more recent evidence casts doubt on its efficacy. [4] [5] Studies of the use of betahistine have shown a reduction in symptoms of vertigo and, to a lesser extent, tinnitus, but conclusive evidence is lacking at present.